MAP 0.00% 17.0¢ microba life sciences limited

catching the knife, page-12

  1. 21,782 Posts.
    Sabretoothed

    Confidence in Macquarie's flagship, MAP, suffered a body blow when its parent extracted a huge 'performance fee' via the May22 AGM - something of a shock for MAP holders. Other resolutions also raised concerns for normal investors.

    I wonder who has the financial power to send it down like this & who stands to gain by doing so? As per another of Macquarie's ASX fleet, IMHO they may soon remove it from trading on the ASX after again buying out investors for a song. IMHO $2.00 is a critical level for MAP.

    MAP June27

    4YIO - NFA
 
watchlist Created with Sketch. Add MAP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.